Earnings Per Share (EPS) is expected to increase by 1.3% to $0.81.
Projected revenue growth of 11.7% to $321 million indicates a positive financial trend.
The company’s price-to-earnings (P/E) ratio stands at 90.53, reflecting high investor expectations.
HealthEquity, Inc. (NASDAQ:HQY) is a leading provider of health savings accounts (HSAs) and other consumer-directed benefits. The company is known for its innovative financial products that help manage healthcare expenses. Competing in the financial services sector within healthcare, HealthEquity aims to deliver exceptional value to its customers.
On June 3, 2025, HealthEquity is scheduled to release its quarterly earnings. Analysts have forecasted an EPS of $0.81, marking a 1.3% increase from the previous year. This growth is primarily due to an expected revenue increase to $321 million, up 11.7% year-over-year, showcasing the company’s robust financial health.
The consensus EPS estimate has seen a minor adjustment, decreasing by 0.2% over the last 30 days. These revisions are crucial as they can influence investor sentiment and potentially affect the company’s stock price. The relationship between earnings estimate trends and stock price movements is well-documented, underscoring the importance of these adjustments for investors.
HealthEquity’s market valuation is evidenced by its P/E ratio of 90.53 and a price-to-sales ratio of 7.29. These figures indicate that the market has high expectations for the company’s future growth. Furthermore, HealthEquity’s financial stability is demonstrated by a current ratio of 3.06 and a debt-to-equity ratio of 0.52, highlighting its strong financial position and balanced financing strategy.
